OptimizeRx 10-Q: Q3 Revenue Down 17%, Net Income $1.2M, Material Weakness Persists
OPRX sits 62% above its 52-week low of $4.54 on elevated volume (3.3× avg).
Summary
OptimizeRx's Q3 10-Q shows revenue down 17% to $21.6M but net income of $1.2M ($0.06/share) on cost cuts, retention sliding to 83%, and a previously identified material weakness in disclosure controls still not fully remediated.
Key Events · Earnings and Guidance · OPRX
-
Q3 Revenue Falls 17%
Net revenue was $21,615K versus $26,067K a year ago, and nine-month revenue fell 20% to $61,963K from $77,190K.
-
Cost Cuts Lift Profitability
Total expenses dropped 21% to $18,945K, producing operating income of $2,670K and net income of $1,195K, or $0.06 per diluted share.
-
Retention Slides to 83%
Net revenue retention fell to 83% from 121%, and a customer that was about 10% of fiscal 2025 revenue generated no revenue this period.
-
Material Weakness Still Open
Disclosure controls were not effective due to a previously identified material weakness over third-party service organization data; three of four providers are remediated and one remains in process.
Analysis · OPRX · Trade & Services
The 10-Q confirms the quarter the 8-K flagged: revenue fell 17% to $21.6M while cost cuts lifted operating income to $2.7M and net income to $1.2M, or $0.06 a share. Demand is the bigger issue — net revenue retention dropped to 83% from 121% as large accounts cut spend, and one customer that was ~10% of 2025 revenue generated nothing this period. The filing also restates that disclosure controls were not effective because of a previously identified material weakness tied to third-party service organization data, with one of four providers still being remediated. The balance sheet is the offset: $22.3M cash, $42.5M working capital, debt paid down to $13.4M and a further $3.0M repaid on October 19, 2026.
How filings like this one have moved
In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, OPRX was trading at $7.34 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $138.3M. The 52-week trading range was $4.54 to $16.37. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.